According to GlobalData’s medical device pipeline database, 29 Sterilization Equipment devices are in various stages of development globally. GlobalData’s report Sterilization Equipment provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 15 are in active development, while the remaining 14 are in an inactive stage of development. There are 12 products in the early stages of development, and the remaining three are in the late stages of development.
Hospital Supplies are the basic commodities required in the hospital to effectively examine, diagnose, and treat the disease or injury of patients. Sterilization equipment is used to kill all the microbes (sterilization) from objects, and is essential equipment to support normal hospital processes, such as sterilization of surgical instruments, laboratory reagents and so forth. Based on its application, sterilization is of three types: physical, chemical and ultraviolet. Physical sterilizers use various forms of heat to sterilize objects, including steam or flame. Physical sterilizers include autoclaves and other high temperature sterilizers. This segment covers steam sterilizers and hot air ovens (dry heat). Chemical sterilizers are used for equipment that is sensitive to high temperatures, susceptible to corrosion (metal alloys) and for devices that might be damaged by irradiation (rubbers and plastics may become brittle after irradiation). The Chemical Sterilizers segment covers ethylene oxide, hydrogen peroxide and other chemical sterilizers. Chemical Sterilizers are used in the healthcare to chemically treat surgical instruments and medical supplies to ensure infectious agents are not transmitted to patients. Ultraviolet sterilizers use ultraviolet (UV) rays for sterilization. High-efficiency UV lamp systems are used for in-duct, coil mount and stand-alone systems to destroy airborne and surface bio-contaminants.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Sterilization Equipment pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Sterilization Equipment devices. Overall, most of these Sterilization Equipment pipeline devices are being developed by private entities.
Key players involved in the active development of Sterilization Equipment include Advanced Cooling Technologies, Advanced Sterilization Products Services, B.B.R. Medical Innovations, Brighton Development, Case Western Reserve University, Cedars-Sinai Medical Center, Creo Medical, EGOHEALTH, Getinge and HyperMed.
For a complete picture of the developmental pipeline for Sterilization Equipment devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
